These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
372 related items for PubMed ID: 20477810
1. Comprehensive flow cytometry phenotype in acute leukemia at diagnosis and at relapse. Li X, Du W, Liu W, Li X, Li H, Huang SA. APMIS; 2010 May; 118(5):353-9. PubMed ID: 20477810 [Abstract] [Full Text] [Related]
2. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia. Zelezníková T, Babusíková O. Neoplasma; 2006 May; 53(6):500-6. PubMed ID: 17167719 [Abstract] [Full Text] [Related]
3. [Immunophenotyping in acute leukemia: detection of minimal residual disease]. Pálóczi K, Nahajevszky S, Jakab K, Regéczy N, Gopcsa L, László E, Földi J. Orv Hetil; 2000 Nov 12; 141(46):2487-92. PubMed ID: 11126681 [Abstract] [Full Text] [Related]
4. Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring. Langebrake C, Brinkmann I, Teigler-Schlegel A, Creutzig U, Griesinger F, Puhlmann U, Reinhardt D. Cytometry B Clin Cytom; 2005 Jan 12; 63(1):1-9. PubMed ID: 15624201 [Abstract] [Full Text] [Related]
5. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry]. Liu YR, Wang H, Chang Y, Cheng YF, Fu JY, Zhang LP, Liu GL, Chen SS. Zhonghua Xue Ye Xue Za Zhi; 2005 Jun 12; 26(6):327-31. PubMed ID: 16185473 [Abstract] [Full Text] [Related]
6. The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia. Al-Mawali A, Gillis D, Lewis I. Am J Clin Pathol; 2009 Jan 12; 131(1):16-26. PubMed ID: 19095561 [Abstract] [Full Text] [Related]
7. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia]. Wang XB, Zheng JE, Gu JX, Yao JX, Yang J, Liu J, Li XQ, He YL, Yu JM, Wei J, Liu ZP, Huang SA. Ai Zheng; 2005 Jun 12; 24(6):667-71. PubMed ID: 15946475 [Abstract] [Full Text] [Related]
10. Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings. Voskova D, Schoch C, Schnittger S, Hiddemann W, Haferlach T, Kern W. Cytometry B Clin Cytom; 2004 Nov 12; 62(1):25-38. PubMed ID: 15468339 [Abstract] [Full Text] [Related]
11. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease. Babusíková O, Mesárosová A, Koníková M, Kusenda J, Glasová M, Klobusická M. Neoplasma; 1993 Nov 12; 40(5):275-81. PubMed ID: 8272155 [Abstract] [Full Text] [Related]
15. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia. Babusíková O, Glasová M, Koníková E, Kusenda J. Neoplasma; 1996 Nov 12; 43(6):367-72. PubMed ID: 8996560 [Abstract] [Full Text] [Related]
18. [Cells antigens' expression modulation during induction treatment of childhood acute lymphoblastic leukemia]. Pawińska-Wasikowska K, Balwierz W. Przegl Lek; 2010 Nov 12; 67(6):361-5. PubMed ID: 21344762 [Abstract] [Full Text] [Related]
19. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia. Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O. Neoplasma; 2007 Nov 12; 54(6):471-7. PubMed ID: 17949229 [Abstract] [Full Text] [Related]